Athersys, Inc. (ATHXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.00
0.00 (0.00%)
Jan 29, 2025, 4:00 PM EST
Athersys Revenue
Athersys had revenue of $80.00K in the twelve months ending September 30, 2023, down -98.67% year-over-year. In the year 2022, Athersys had annual revenue of $5.33M, down -3.43%.
Revenue (ttm)
80.00K
Revenue Growth
-98.67%
P/S Ratio
0.00
Revenue / Employee
3.33K
Employees
24
Market Cap
62.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 5.33M | -189.00K | -3.43% |
Dec 31, 2021 | 5.51M | 4.07M | 282.92% |
Dec 31, 2020 | 1.44M | -4.19M | -74.44% |
Dec 31, 2019 | 5.63M | -18.66M | -76.81% |
Dec 31, 2018 | 24.29M | 20.58M | 555.10% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
BioStem Technologies | 210.49M |